← Open Payments lookup

KATHERINE SOLAKLI: Open Payments

NPI 1386913556 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,716 in 52 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $703 · 2025 $1,716

Food & beverage: $1,716
CompanyPaymentsAmount
United Therapeutics Corporation17$725
Paratek Pharmaceuticals, Inc.3$166
Boehringer Ingelheim Pharmaceuticals, Inc.7$132
Bayer Healthcare Pharmaceuticals Inc.5$130
Actelion Pharmaceuticals US, Inc.4$112
Merck Sharp & Dohme LLC1$110
ABBVIE INC.4$94
Takeda Pharmaceuticals U.S.A., Inc.3$80
Melinta Therapeutics, LLC3$53
Astellas Pharma US Inc1$32

Products named: Remodulin, Orenitram, NUZYRA, Adempas, UPTRAVI, Tyvaso, OFEV, LIVTENCITY.

Industry payments across DC — which companies pay providers there.